Guidant To Push DES Program In 2005, Says Champion Fracture Issue Solved
This article was originally published in The Gray Sheet
Executive Summary
Guidant expects to launch its Champion everolimus drug-eluting stent in Europe in mid-2005, assuming regulators agree that the firm has resolved stress fracture problems related to the device